212 related articles for article (PubMed ID: 31347930)
21. Substituted 2-thioxothiazolidin-4-one derivatives showed protective effects against diabetic cataract via inhibition of aldose reductase.
Huang W; Zhang Y; Liang X; Yang L
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900371. PubMed ID: 32237167
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5'-imidazolidine]-2',4'-diones.
Iqbal Z; Hameed S; Ali S; Tehseen Y; Shahid M; Iqbal J
Eur J Med Chem; 2015 Jun; 98():127-38. PubMed ID: 26005026
[TBL] [Abstract][Full Text] [Related]
23. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
Bhadada SV; Vyas VK; Goyal RK
Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
[TBL] [Abstract][Full Text] [Related]
25. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.
Chen X; Yang Y; Ma B; Zhang S; He M; Gui D; Hussain S; Jing C; Zhu C; Yu Q; Liu Y
Eur J Med Chem; 2011 May; 46(5):1536-44. PubMed ID: 21367494
[TBL] [Abstract][Full Text] [Related]
27. Antileishmanial potential of fused 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiols: Synthesis, biological evaluations and computational studies.
Patil SR; Asrondkar A; Patil V; Sangshetti JN; Kalam Khan FA; Damale MG; Patil RH; Bobade AS; Shinde DB
Bioorg Med Chem Lett; 2017 Aug; 27(16):3845-3850. PubMed ID: 28693910
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
Wu B; Yang Y; Qin X; Zhang S; Jing C; Zhu C; Ma B
ChemMedChem; 2013 Dec; 8(12):1913-7. PubMed ID: 24115741
[TBL] [Abstract][Full Text] [Related]
29. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
Rastelli G; Ferrari AM; Costantino L; Gamberini MC
Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
[TBL] [Abstract][Full Text] [Related]
30. The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet.
Chang YX; Ge AH; Donnapee S; Li J; Bai Y; Liu J; He J; Yang X; Song LJ; Zhang BL; Gao XM
J Ethnopharmacol; 2015 Apr; 164():210-22. PubMed ID: 25698248
[TBL] [Abstract][Full Text] [Related]
31. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
Celestina SK; Sundaram K; Ravi S
Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, molecular modeling, selective aldose reductase inhibition and hypoglycemic activity of novel meglitinides.
Salem MG; Abdel Aziz YM; Elewa M; Nafie MS; Elshihawy HA; Said MM
Bioorg Chem; 2021 Jun; 111():104909. PubMed ID: 33895603
[TBL] [Abstract][Full Text] [Related]
33. Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications.
Ottanà R; Maccari R; Giglio M; Del Corso A; Cappiello M; Mura U; Cosconati S; Marinelli L; Novellino E; Sartini S; La Motta C; Da Settimo F
Eur J Med Chem; 2011 Jul; 46(7):2797-806. PubMed ID: 21531055
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors.
Hussain S; Parveen S; Hao X; Zhang S; Wang W; Qin X; Yang Y; Chen X; Zhu S; Zhu C; Ma B
Eur J Med Chem; 2014 Jun; 80():383-92. PubMed ID: 24793885
[TBL] [Abstract][Full Text] [Related]
35. Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Mohd Siddique MU; Thakur A; Shilkar D; Yasmin S; Halakova D; Kovacikova L; Prnova MS; Stefek M; Acevedo O; Dasararaju G; Devadasan V; Mondal SK; Jayaprakash V
Eur J Med Chem; 2021 Nov; 223():113630. PubMed ID: 34175538
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and activity of a new series of (Z)-3-phenyl-2-benzoylpropenoic acid derivatives as aldose reductase inhibitors.
Wang SJ; Yan JF; Hao D; Niu XW; Cheng MS
Molecules; 2007 Apr; 12(4):885-95. PubMed ID: 17851441
[TBL] [Abstract][Full Text] [Related]
37. Exploring the interactional details between aldose reductase (AKR1B1) and 3-Mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid through molecular dynamics simulations.
Zhan JY; Ma K; Zheng QC; Yang GH; Zhang HX
J Biomol Struct Dyn; 2019 Apr; 37(7):1724-1735. PubMed ID: 29671687
[TBL] [Abstract][Full Text] [Related]
38. The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer's disease, anti-diabetic, and anti-inflammatory activities.
Choi JS; Islam MN; Ali MY; Kim YM; Park HJ; Sohn HS; Jung HA
Arch Pharm Res; 2014 Oct; 37(10):1354-63. PubMed ID: 24988985
[TBL] [Abstract][Full Text] [Related]
39. Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
Metwally K; Pratsinis H; Kletsas D; Quattrini L; Coviello V; Motta C; El-Rashedy AA; Soliman ME
Future Med Chem; 2017 Dec; 9(18):2147-2166. PubMed ID: 29098865
[TBL] [Abstract][Full Text] [Related]
40. Green fluorescent protein chromophore derivatives as a new class of aldose reductase inhibitors.
Saito R; Hoshi M; Kato A; Ishikawa C; Komatsu T
Eur J Med Chem; 2017 Jan; 125():965-974. PubMed ID: 27769036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]